TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited announced that Dr. Lisa McIntyre will not seek re-election and will step down from the Board on November 5, 2025. Dr. McIntyre has been a significant contributor to the company, particularly as Chair of the Innovation & Development Committee. Her departure prompts the company to begin a search for a new director. Dr. Larry Marshall will take over as Chair of the Innovation & Development Committee. This leadership change reflects Nanosonics’ ongoing commitment to innovation and maintaining strong governance.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products that enhance patient safety and improve healthcare outcomes.
Average Trading Volume: 760,084
Technical Sentiment Signal: Buy
Current Market Cap: A$1.3B
See more insights into NAN stock on TipRanks’ Stock Analysis page.